Table 2.
Clinical data of patients.
| Factors | Observation group (n = 76) | Control group (n = 64) | t/χ2/Z value | P value |
|---|---|---|---|---|
| Gender | ||||
| Male | 45 (59.21) | 42 (65.63) | 0.608 | 0.436 |
| Female | 31 (40.79) | 22 (34.38) | ||
| Age | 57.0 ± 6.4 | 56.4 ± 6.2 | 0.561 | 0.576 |
| BMI (kg/m2) | 23.65 ± 1.82 | 24.04 ± 1.97 | 1.216 | 0.226 |
| Past medical history | ||||
| Hypertension | 19 (25.00) | 21 (32.81) | 1.039 | 0.308 |
| Diabetes | 13 (17.11) | 10 (15.63) | 0.055 | 0.814 |
| Hyperlipidemia | 8 (10.53) | 8 (12.50) | 0.134 | 0.715 |
| History of smoking | ||||
| Yes | 19 (25.00) | 18 (28.13) | 0.175 | 0.676 |
| No | 57 (75.00) | 46 (71.88) | ||
| History of alcohol abuse | ||||
| Yes | 9 (11.84) | 10 (15.63) | 0.424 | 0.515 |
| No | 67 (88.16) | 54 (84.38) | ||
| Place of residence | ||||
| City | 58 (76.32) | 50 (78.13) | 0.065 | 0.800 |
| Rural | 18 (23.68) | 14 (21.88) | ||
| Platelet count (×109/L) | 152.93 ± 54.41 | 147.23 ± 51.62 | 0.632 | 0.528 |
| Total cholesterol (mmol/L) | 6.58 ± 0.87 | 6.54 ± 0.83 | 0.782 | 0.277 |
| Triglyceride (mmol/L) | 3.32 ± 0.74 | 3.47 ± 0.81 | 1.144 | 0.255 |
| Location of infarction | ||||
| Frontal lobe | 12 (15.79) | |||
| Temporal lobe | 10 (13.16) | |||
| Parietal lobe | 9 (11.84) | |||
| Occipital lobe | 9 (11.84) | |||
| Basal ganglia | 10 (13.16) | |||
| Thalamus | 11 (14.47) | |||
| Cerebellum | 10 (13.16) | |||
| Brainstem | 5 (6.58) | |||
| Infarct size | ||||
| Lacunar infarction | 39 (51.32) | |||
| Medium area infarction | 23 (30.26) | |||
| Massive infarction | 14 (18.42) |